Matches in SemOpenAlex for { <https://semopenalex.org/work/W2964756619> ?p ?o ?g. }
Showing items 1 to 60 of
60
with 100 items per page.
- W2964756619 abstract "e14108 Background: Biopsy-driven clinical trials are essential to develop personalized therapeutics, since many critical questions are best addressed in the tumor tissue being treated. In the metastatic setting, intrinsic resistance occurs even with the most advanced therapeutic agents, and even in responders, acquired resistance is inevitable. We have designed a prospective study to identify biomarkers of clinical resistance to standard first-line therapy (FOLFOX, XELOX or FOLFIRI in combination with bevacizumab in patients with metastatic CRC (NCT00984048). Methods: Eligible patients have confirmed metastatic CRC, measurable disease, and consent to three needle-core biopsies (NCBs) of a non-resectable liver metastasis before treatment and at resistance. This study is approved at several Quebec hospitals, demonstrating that Research Ethics Boards recognize the value of biopsy-driven studies without therapeutic benefit. Results: Forty patients agreed to partake in this multi-center trial and to provide NCBs. Of these, 5% were non-neoplastic, and 5% had neuroendocrine origins. Using standard operating procedures developed for this trial, we were able to both preserve morphology and obtain high-quality genomic material. We demonstrate that this material is suitable for DNA analysis (array comparative genomic, methylation profiling) and RNA analysis (gene expression profiling, splicing isoforms variants and micro RNA profiling). In parallel, we have generated resistant CRC cell lines resistant to the combination therapy to further study biomarkers of resistance. Challenges in obtaining a biopsy at time of progression include death, patient refusal, heterogeneity of tumors, metastasis at a different organ site, and time constraints for re-biopsy. No significant adverse events were reported related to the biopsy procedure. Conclusions: We conclude that obtaining serial liver NCBs are challenging, but safe and feasible in metastatic CRC patients with unresectable liver disease. This study will provide insight on the relevance of metastatic tissue in assessing signatures of clinical resistance." @default.
- W2964756619 created "2019-08-13" @default.
- W2964756619 creator A5055280080 @default.
- W2964756619 date "2012-05-20" @default.
- W2964756619 modified "2023-09-27" @default.
- W2964756619 title "Feasibility and challenges of a biopsy-driven and biomarker discovery clinical trial in metastatic colorectal cancer to identify signatures of clinical resistance." @default.
- W2964756619 doi "https://doi.org/10.1200/jco.2012.30.15_suppl.e14108" @default.
- W2964756619 hasPublicationYear "2012" @default.
- W2964756619 type Work @default.
- W2964756619 sameAs 2964756619 @default.
- W2964756619 citedByCount "0" @default.
- W2964756619 crossrefType "journal-article" @default.
- W2964756619 hasAuthorship W2964756619A5055280080 @default.
- W2964756619 hasConcept C121608353 @default.
- W2964756619 hasConcept C126322002 @default.
- W2964756619 hasConcept C143998085 @default.
- W2964756619 hasConcept C185592680 @default.
- W2964756619 hasConcept C2775934546 @default.
- W2964756619 hasConcept C2781197716 @default.
- W2964756619 hasConcept C526805850 @default.
- W2964756619 hasConcept C535046627 @default.
- W2964756619 hasConcept C55493867 @default.
- W2964756619 hasConcept C71924100 @default.
- W2964756619 hasConceptScore W2964756619C121608353 @default.
- W2964756619 hasConceptScore W2964756619C126322002 @default.
- W2964756619 hasConceptScore W2964756619C143998085 @default.
- W2964756619 hasConceptScore W2964756619C185592680 @default.
- W2964756619 hasConceptScore W2964756619C2775934546 @default.
- W2964756619 hasConceptScore W2964756619C2781197716 @default.
- W2964756619 hasConceptScore W2964756619C526805850 @default.
- W2964756619 hasConceptScore W2964756619C535046627 @default.
- W2964756619 hasConceptScore W2964756619C55493867 @default.
- W2964756619 hasConceptScore W2964756619C71924100 @default.
- W2964756619 hasLocation W29647566191 @default.
- W2964756619 hasOpenAccess W2964756619 @default.
- W2964756619 hasPrimaryLocation W29647566191 @default.
- W2964756619 hasRelatedWork W1996031455 @default.
- W2964756619 hasRelatedWork W2102786125 @default.
- W2964756619 hasRelatedWork W2155139792 @default.
- W2964756619 hasRelatedWork W2230512165 @default.
- W2964756619 hasRelatedWork W2299795119 @default.
- W2964756619 hasRelatedWork W2784307064 @default.
- W2964756619 hasRelatedWork W2794215802 @default.
- W2964756619 hasRelatedWork W2805678493 @default.
- W2964756619 hasRelatedWork W2889263662 @default.
- W2964756619 hasRelatedWork W2903169604 @default.
- W2964756619 hasRelatedWork W2978527819 @default.
- W2964756619 hasRelatedWork W2990386727 @default.
- W2964756619 hasRelatedWork W2999060565 @default.
- W2964756619 hasRelatedWork W3011014442 @default.
- W2964756619 hasRelatedWork W3046517487 @default.
- W2964756619 hasRelatedWork W3093041399 @default.
- W2964756619 hasRelatedWork W3106069789 @default.
- W2964756619 hasRelatedWork W3159090482 @default.
- W2964756619 hasRelatedWork W3175107263 @default.
- W2964756619 hasRelatedWork W66730794 @default.
- W2964756619 isParatext "false" @default.
- W2964756619 isRetracted "false" @default.
- W2964756619 magId "2964756619" @default.
- W2964756619 workType "article" @default.